[Zurück zum

Ein systematisches Review zu komplementären und alternativen Therapieverfahren bei Insomnie

Insomnia has been classically seen as a symptom of psychopathology and especially of major depression and it was supposed to remit once depressive symptoms were treated. However, clinical observation has repeatedly shown that insomnia can exist even many years before depression, and that it does not remit after successful treatment of depression. Nowadays, insomnia is considered an independent diagnostic entity. Moreover, it has been shown that insomnia leads to an increased risk of numerous psychiatric or medical illnesses, thus being linked with a high healthcare expense and consume. Efficacious treatments for insomnia (as benzodiazepines or cognitive-behavioural treatment) are still scarcely administered, while the majority of people afflicted by an insomnia disorder tend to self-provide to their own treatment through assuming or attending complementary and alternative medicine or treatments. Of those, however, there is little scientific knowledge and there is a need to systematically and quantitatively summarize the results of the studies conducted to evaluate their efficacy. If these procedures have a null or a worsening effect, this means that insomnia is left to treatments which allow even increasing reduced quality of life and increased risks for psychopathology and medical illnesses. Furthermore, in order to disseminate the efficacious psychological treatments of insomnia (CBT-I), a number of self-help or internet procedures have been proposed and tested. It is of extreme relevance to consider these procedures in a systematic review or meta-analysis, as these could be an elective way to reduce the gap between scientific progress and clinical practice. The proposed research has the following aims: 1) A systematic review will rigorously identify and evaluate studies on CAM, OCAT and CAW; 2) Meta-analyses will be performed on the most important outcome measures; 3) Analyses including covariates will allow to assess patient-related or other factors contributing significantly to better or worse treatment outcome; 4) Quality of the studies available up to now will be evaluated; 5) Based on these analyses, research and clinical recommendations will be formulated. Those will include proposals for the definition of “clinically relevant” and “clinically irrelevant” margins for superiority trials and non-inferiority trials.

Ansprechpartner: Baglioni, C
Tel: 0761-270-65890
Email: chiara.baglioni@uniklinik-freiburg.de
Projektbeginn: 01.02.2012
Projektende: 31.01.2013
Riemann, D, Baglioni, C, Feige, B, Spiegelhalder, K, Nissen, C
Stellvertretung: Spiegelhalder, K
Albert-Ludwigs-Universität Freiburg
Zentrum für Psychische Erkrankungen (Department)
Klinik für Psychiatrie und Psychotherapie
Hauptstrasse 5
79104 Freiburg

Telefon: +49 / 761 / 270-6501 / -6502
Fax: +49 / 761 / 270-6619
Dr. Pittler, Dr. Rücker, dt. Cochrane Zentrum, Freiburg



    Insomnie, alternative Therapien

Aktueller Forschungsbericht